DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.88+0.37 (+3.21%)
Close on Nov 11, 2026Market cap $746.99MP/E –Yield –
Earnings
DBV Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 25, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.14
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of DBV Technologies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026after the close | – | – | -$0.14 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 16, 2026during market hours | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026during market hours | – | – | -$0.11 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 26, 2026during market hours | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 29, 2025during market hours | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 29, 2025during market hours | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025during market hours | – | – | -$0.26 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 24, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 22, 2024during market hours | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 30, 2024during market hours | $1.20M | -47.8% | -$0.34 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024during market hours | – | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 7, 2024during market hours | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 31, 2023during market hours | $2.40M | +15.7% | -$0.17 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 31, 2023during market hours | $2.30M | +50.4% | -$0.26 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023during market hours | $2.20M | -13.6% | -$0.22 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 3, 2023during market hours | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022during market hours | $2.07M | +56.8% | -$0.18 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 1, 2022during market hours | $1.53M | – | -$0.35 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 2, 2022during market hours | $2.55M | – | -$0.30 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 3, 2022during market hours | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 26, 2021during market hours | $1.32M | – | -$0.44 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 2, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 3, 2021during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
DBV Technologies has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When DBV Technologies puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases DBV Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- News
- Results
- Results
- News
- News
- News
- Update
- Results
- Update
- News
- Results
- News
See a number that looks wrong?